Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.

The aim of the study is to evaluate the effects of Herbal gargle on chemoradiotherapy-induced stomatitis in head & neck cancer patients.

Study Overview

• Status: Not yet recruiting
• Conditions: Head and Neck Neoplasms; Chemoradiotherapy; Stomatitis and Ulceration
• Intervention / Treatment: Drug: Herbal gargle; Other: Normal saline

Detailed Description

Head and neck cancer accounts for about 5% of all cancers worldwide with the age-standardized incidence rate (ASIR) of HNC increased by 5.4% per year among males and 3.1% among females in Taiwan. Concurrent chemoradiotherapy (CCRT) is the most common management to treat head and neck cancer. However, CCRT may cause much side effects such as oral mucositis, radiation dermatitis, xerostomia, or infection, which influence food intake, disturb nutritional status and interrupt the course of treatment. Traditional Chinese Medicine (TCM) has been applied to treat cancer side effects for many years. Herbal gargle is composed of TCM herbals used for oral mucositis induced by chemoradiotherapy among head and neck cancer. The aim of the trial is to evaluate the effectiveness of Herbal gargle. The participants divide into two groups, treatment group and control group. The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks. The control group receive normal saline 150ml for oral mucositis. The subjective questionnaires of EORTC QLQ-C30, EORTC QLQ-H&N35 are assessed twice a week, CTCAE for grading of oral mucositis is assessed once a week, VAS is assessed everyday for 8 weeks. Besides, change of opioid dosage, body weight are also recorded. The CRP is assessed before and every week for 8 weeks and the albumin and bacteria culture are assessed before and post-treatment of 4th week and 8th week. The baseline difference of treatment and control group will be analyzed by using independent t-test and the difference of evaluation scores and blood tests between pre-treatment and post-treatment will be analyzed using multivariate logistic regression analysis. A value of P < 0.05 will be regarded as statistically significant for the above statistical analyses.

• Study Type: Interventional
• Enrollment (Anticipated): 80
• Phase: Phase 2

Contacts and Locations

• Study Contact: Name: Yi-Hsine Shiao, Doctor; Phone Number: 2777 24313131; Email: vincentking44@gmail.com

Study Locations

• Taiwan
  • Keelung, Taiwan
    • Keelung, Keelung, Taiwan, Taiwan, 20401
      • Keelung Chang Gung Memorial Hospital
      • Contact: Yi-Hsine Shiao, Doctor; Phone Number: 2777 24313131; Email: vincentking44@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Willing to join the trial project and sign the informed consent form.
• Age more than 20 years-old.
• Pathology proved to be head and neck cancers.
• Head and neck cancer patients under radiotherapy or concurrent chemoradiotherapy.
• Expected life expectancy more than 3 months.
• Subjects with clear consciousness and can be assessed cooperatively.
• Subjects are suitable to use Herbal gargle evaluated by Traditional Chinese medicine physicians.

Exclusion Criteria:

• Subjects can not sing the informed consent form.
• Systemic infection.
• Heart, liver and kidney insufficiency
• Allergy history of Traditional Chinese medicine
• Unclear conscious to use Herbal gargle.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Treatment group; The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.	Drug: Herbal gargle; The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.
Sham Comparator: Control group; The control group receive Normal saline 150ml and are instructed to hold the normal saline in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.	Other: Normal saline; The control group receive Normal saline 150ml and are instructed to hold the normal saline in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change of CTCAE 4.0	CTCAE is used to describe the severity of oral mucositis for patients receiving cancer therapy.	change from baseline and every week for 8 weeks.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change of EORTC QLQ-C30	European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire score, EORTC QLQ-C30, is used to measure cancer patients' physical, psychological and social functions.	change from baseline at 4 weeks and 8 weeks post treatment.
Change of EORTC QLQ-H&N35	European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-head & neck, EORTC QLQ-H&N35, is used for assessing the health-related quality of life for head-and-neck cancer patients.	change from baseline at 4 weeks and 8 weeks post treatment.
Change of VAS of pain of oral mucositis	Visual Analogue Scale, VAS, is used to to measure the intensity of pain of oral mucositis.	change from baseline and everyday for 8 weeks.
Change of body weight	The oral mucositis caused by chemoradiotherapy will influence food intake. Monitor body weight provides objective evaluation of nutrition status.	change from baseline and every week for 8 weeks.
Change of opioid use	Opioid analgesics is often prescribed for alleviating pain from oral mucositis. Monitor opioid use provides other evaluation for severity of pain and wound healing.	change from baseline and every week for 8 weeks.
Change of albumin	Albumin has been used as maker of nutrition status.	change from baseline at 4 weeks and 8 weeks post treatment.
Change of CRP	C-reactive protein is used to monitor severity of oral mucositis.	change from baseline and every week for 8 weeks.
Change of common aerobic culture	Aerobic culture is used to monitor the change of bacteria flora before and after Herbal gargle treatment.	change from baseline and every week for 8 weeks.

Collaborators and Investigators

• Sponsor: Chang Gung Memorial Hospital

Study record dates

Study Major Dates

• Study Start (Anticipated): April 15, 2022
• Primary Completion (Anticipated): May 15, 2025
• Study Completion (Anticipated): December 31, 2025

Study Registration Dates

• First Submitted: April 18, 2022
• First Submitted That Met QC Criteria: April 18, 2022
• First Posted (Actual): April 22, 2022

Study Record Updates

• Last Update Posted (Actual): April 22, 2022
• Last Update Submitted That Met QC Criteria: April 18, 2022
• Last Verified: April 1, 2022

More Information

Terms related to this study

• Keywords: Chemoradiotherapy; Head and Neck Neoplasms; Medicine, Chinese Traditional; Stomatitis and Ulceration
• Additional Relevant MeSH Terms: Digestive System Diseases; Pathologic Processes; Neoplasms; Neoplasms by Site; Gastrointestinal Diseases; Gastroenteritis; Stomatognathic Diseases; Mouth Diseases; Ulcer; Head and Neck Neoplasms; Mucositis; Stomatitis
• Other Study ID Numbers: 202101017A3

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No